🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Nikolaos P. Polyzos

Hospital Universitario Dexeus

ORCID: 0000-0001-6161-0011
MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 6 papers. Top paper: “Survival With Aromatase Inhibitors and Inactivators Versus Standard Hormonal Therapy in Advanced Breast Cancer: Meta-analysis”.

Survival With Aromatase Inhibitors and Inactivators Versus Standard Hormonal Therapy in Advanced Breast Cancer: Meta-analysis

JNCI: Journal of the National Cancer Institute(2006)10.1093/jnci/djj357
N/A
0.849DataRank · unranked
286 citations

Nicholas Pavlidis, Nikolaos P. Polyzos, John P. A. Ioannidis, Davide Mauri

Selective discussion and transparency in microarray research findings for cancer outcomes

European Journal of Cancer(2007)10.1016/j.ejca.2007.05.019
N/A
0.736DataRank · unranked
21 citations

Nikolaos P. Polyzos, Thomas A. Trikalinos, John P. A. Ioannidis

Blastocyst versus cleavage embryo transfer improves cumulative live birth rates, time and cost in oocyte recipients: a randomized controlled trial

Reproductive BioMedicine Online(2022)10.1016/j.rbmo.2022.01.001
N/A
0.505DataRank · unranked
28 citations

Ignacio Rodríguez, Gemma Arroyo, Annalisa Racca, Francisca Martínez, Nikolaos P. Polyzos +1 more

Industry involvement and baseline assumptions of cost-effectiveness analyses: diagnostic accuracy of the Papanicolaou test

Canadian Medical Association Journal(2011)10.1503/cmaj.101506
N/A
0.477DataRank · unranked
23 citations

A. Valachis, Nikolaos P. Polyzos, Antonis Valachis, Davide Mauri, John P. A. Ioannidis

Randomized evidence on chemotherapy and hormonal therapy regimens for advanced endometrial cancer: An overview of survival data

European Journal of Cancer(2006)10.1016/j.ejca.2005.09.026
N/A
0.434DataRank · unranked
17 citations

Nicholas Pavlidis, Evangelos Paraskevaidis, John P. A. Ioannidis, Nikolaos P. Polyzos

Guidelines on Chemotherapy in Advanced Stage Gynecological Malignancies: An Evaluation of 224 Professional Societies and Organizations

PLoS ONE(2011)10.1371/journal.pone.0020106
N/A
0.269DataRank · unranked
5 citations

Davide Mauri, John P. A. Ioannidis, Nikolaos P. Polyzos